Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

Honglian Gui,Changqing Zhao,Yan Wang,Hong-Tu Gu,Wei Jing Wang,Wei Cai,Qing Guo,Shisan Bao,Lie-Ming Xu,Qing Xie

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

2020

Honglian Gui
Changqing Zhao
Yan Wang
Hong-Tu Gu
Wei Jing Wang
Wei Cai
Qing Guo
Shisan Bao
Lie-Ming Xu
Qing Xie

Background and Aims: To evaluate the efficacy of Fuzheng Huayu (FZHY), a Chinese herbal formula, plus entecavir (ETV) in regression of liver fibrosis in chronic hepatitis B (CHB) patients with significant fibrosis/cirrhosis.

Keywords:

significant fibrosis
Internal medicine
Entecavir
chronic hepatitis
Fuzheng huayu
Gastroenterology
Combination therapy
Cirrhosis
Fibrosis
liver fibrosis
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations